Evidence map›Paper›PMID 24265555›Full record

ArticleVascular health and risk management2013

Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk.

Hong Lai, Elliot K Fishman, Gary Gerstenblith, Richard Moore, Jeffrey A Brinker, Jeanne C Keruly, Shaoguang Chen, Barbara Detrick, Shenghan Lai

Open access · goldAbstract read
In one paragraph

Article in Vascular health and risk management, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Observational
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hong LaiDepartment of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Elliot K Fishman
Gary Gerstenblith
Richard Moore
Jeffrey A Brinker
Jeanne C Keruly
Shaoguang Chen
Barbara Detrick
Shenghan Lai
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Bryan Lau · 2012 to 2026
$67.0M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
HIV DISEASE OUTCOMES IN DRUG USERS IN CLINICAL PRACTICER01DA011602 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 1998 to 2013
$10.8M
Subclinical Atherosclerosis in HIV plus Black Cocaine UsersR01DA012777 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LAI, SHENGHAN · 1999 to 2014
$8.2M
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African AmericansR01DA025524 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LAI, SHENGHAN · 2008 to 2012
$3.8M
HIV, Cocaine &Regional Left Ventricular DysfunctionR01DA015020 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LAI, SHENGHAN · 2002 to 2006
$3.4M
NIAID NIH HHS P30 AI094189NIDA NIH HHS DA15020NIDA NIH HHS DA25524NIDA NIH HHS R01 DA011602NIDA NIH HHS R01 DA012777NIDA NIH HHS R01 DA015020NIDA NIH HHS R01 DA025524NIDA NIH HHS R01-DA 12777NIDA NIH HHS U01 DA036935
6 · The paper itself

Abstract

unlabelledChronic cocaine use may lead to premature atherosclerosis, but the prevalence of and risk factors for coronary artery disease (CAD) in asymptomatic cocaine users have not been reported. The objective of this study was to examine whether vitamin D deficiency is associated with the development of CAD in human immunodeficiency virus (HIV)-infected African American cocaine users with low CAD risk.

methodsIn this prospective follow-up study, we investigated 169 HIV-infected African American cocaine users with low Framingham risk at baseline. The main outcome measures were incidence of subclinical CAD and development of subclinical CAD.

resultsFifty of the 169 African Americans had evidence of subclinical disease on the initial cardiac computed tomography. A second cardiac computed tomography was performed on the 119 African Americans without disease on the first scan. The total sum of person-years of follow-up was 289.6. Subclinical CAD was detected in 11 of these, yielding an overall incidence of 3.80/100 person-years (95% confidence interval 1.90-6.80). Among the factors investigated, only vitamin D deficiency was independently associated with development of subclinical CAD. The study did not find significant associations between CD4 count, HIV viral load, or antiretroviral treatment use and the incidence of subclinical CAD. This study appears to suggest that there is a threshold level of vitamin D (10 ng/mL) above which the effect of vitamin D on subclinical CAD is diminished.

conclusionThe incidence of subclinical CAD in HIV-infected African American cocaine users with low CAD risk is high, especially in those with vitamin D deficiency. Well designed randomized clinical trials are warranted to confirm the role of vitamin D deficiency in the development of CAD in HIV-infected African American cocaine users with low CAD risk.

Indexed as

Black or African AmericanDrug UsersAsymptomatic DiseasesBaltimoreCocaine-Related DisordersCoronary AngiographyCoronary Artery DiseaseFemaleFollow-Up StudiesHIV InfectionsHumansIncidenceKaplan-Meier EstimateMaleMiddle AgedMultidetector Computed TomographyAfrican Americanscocaine useprospective follow-up studysubclinical coronary artery diseasevitamin D deficiency

Identifiers

PMID24265555
PMCPMC3833705
OpenAlexW2060377413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.